-- 深圳力拓機器人(港交所代號:1236)於週四啟動香港首次公開發行(IPO),擬募集資金至多約10億港元。 根據香港交易所公告,這家總部位於中國的機器人公司將發行3,330萬股,指示性發行價區間為每股24港元至30港元。 此次發行包括面向香港投資者的330萬股及麵向國際投資者的3,000萬股,具體發行數量將根據市場狀況進行調整,並視超額配售權而定。 發行價預計5月7日確定,配售結果將於5月8日公佈,公司計劃於5月11日正式上市交易。 募集資金淨額將主要用於加強智慧機器人視覺和人工智慧驅動技術的研究與開發,以及支援新產品開發。 此外,募集資金也將用於擴大產能、提升製造能力、加強國際擴張和品牌建設,以及用於營運資金和一般公司用途。 海通國際資本、國泰君安資本擔任聯合保薦人。 海通國際證券及國泰君安證券(香港)擔任總協調人,並與中國國際金融股份有限公司(香港)證券及國投證券(香港)共同擔任聯席帳簿管理人及聯席主承銷商。 富途證券國際(香港)、東方證券(香港)、中國工商銀行證券及悅祥國際證券擔任聯席帳簿管理人及聯席主承銷商。
Related Articles
Hyundai Motor Group, Georgia Institute of Technology Enter Multi-Year Partnership for Hydrogen Mobility Solutions
Hyundai Motor Group, the parent of Hyundai Motor (KRX:005380) and Kia (KRX:000270), entered a multi-year partnership with the Georgia Institute of Technology to jointly develop hydrogen mobility solutions, according to a Thursday release.The agreement is expected to advance hydrogen-powered transportation, boost applied research, and hasten the use of zero-emissions vehicles in Georgia, it said.Under the partnership, Hyundai Motor North America will donate four NEXO fuel cell electric SUVs, and Hyundai Motor Group will donate a hydrogen electrolyzer project, which will be used exclusively on campus, the release said.Shares of Hyundai Motor fell more than 3% in recent trade, while those of Kia fell over 2%.
Joinn Laboratories' Profit Surges 480% in Q1
Joinn Laboratories (HKG:6127, SHA:603127) posted net profit attributable to shareholders of 238.4 million yuan for the first quarter, up 480% from 41.1 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the drug research firm were down over 6% in Thursday's late-morning trade.Earnings per share came in at 0.32 yuan, up from 0.05 yuan a year earlier.Revenue increased 10% to 316.1 million yuan from 287.3 million yuan in the prior-year period.
Wingtech's Losses Deepen in 2025 Amid Nexperia Control Dispute
Wingtech's (SHA:600745) losses widened in 2025 as it continues to grapple with a complex dispute involving its semiconductor subsidiary, Nexperia.The Chinese semiconductor company's net loss attributable to shareholders ballooned to 8.75 billion yuan from 2.83 billion yuan a year earlier, according to a Shanghai bourse filing on Thursday.Loss per share widened to 7.03 yuan from 2.28 yuan a year earlier.Operating revenue dropped 58% to 31.3 billion yuan from 73.6 billion yuan in the previous year.The primary driver behind the decline was the loss of control over Nexperia in 2025. Following a seizure by the Dutch government over national security concerns regarding technology exports, Wingtech's production capabilities were severely disrupted.While Wingtech eventually secured licensing exemptions for semiconductor exports from Nexperia, its control over several of the unit's overseas entities remain restricted.As a result of the Nexperia fallout, Wingtech said it booked an investment loss of 8.95 billion yuan in 2025."The company is actively pursuing legal remedies and simultaneously advancing domestic supply chain development, relying on existing domestic capacity to ensure supply to customers in China and globally, while safeguarding shareholder interests," Wingtech said.Wingtech added that Nexperia China is working with Chinese partners to actively establish and integrate its transistor product lines.The downward trend persisted into the first quarter of 2026, with Wingtech reporting an attributable loss of 189.3 million yuan, versus an attributable profit of 261.4 million yuan a year earlier.Loss per share stood at 0.15 yuan, compared with earnings per share of 0.21 yuan a year prior.Operating revenue in Q1 plummeted 94% to 816.4 million yuan from 13.1 billion yuan in the preceding year.Despite these challenges, the broader Chinese semiconductor industry is pushing self-sufficiency in response to trade restrictions from the US and other partners.Analysts suggest that rising local demand and the use of domestic solutions to bridge the "compute gap" could help stabilize revenue for the sector later this year, CNBC reported earlier in April.